Adherence to treatment, arterial stiffness and cognitive function in irbesartan-treated newly diagnosed hypertensive patients.
Sign Up to like & getrecommendations! Published in 2020 at "Current vascular pharmacology"
DOI: 10.2174/1570161119666201120160104
Abstract: OBJECTIVE Non-adherence to antihypertensive agents leads to reduced blood pressure (BP) control. Data supporting the correlation of adherence with arterial stiffness (AS) are few. Furthermore, the causal relationship between AS and cognitive dysfunction (CO/DY) has… read more here.
Keywords: arterial stiffness; mmhg 005; irbesartan; hypertensive patients ... See more keywords
Virtual Screening of Novel 24-Dehydroxysterol Reductase (DHCR24) Inhibitors and the Biological Evaluation of Irbesartan in Cholesterol-Lowering Effect
Sign Up to like & getrecommendations! Published in 2023 at "Molecules"
DOI: 10.3390/molecules28062643
Abstract: Hyperlipidemia is a risk factor for the development of fatty liver and cardiovascular diseases such as atherosclerosis and coronary heart disease, and hence, cholesterol-lowering drugs are considered important and effective in preventing cardiovascular diseases. Thus,… read more here.
Keywords: hyperlipidemia; cholesterol lowering; activity; irbesartan ... See more keywords